SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics

mRNA- and vector-based vaccines are used at a large scale to prevent COVID-19. We compared Spike S1-specific (S1) IgG antibodies after vaccination with mRNA-based (Comirnaty, Spikevax) or vector-based (Janssen, Vaxzevria) vaccines, using samples from a Dutch nationwide cohort. In adults 18–64 years...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Hoogen, Lotus L., Verheul, Marije K., Vos, Eric R. A., van Hagen, Cheyenne C. E., van Boven, Michiel, Wong, Denise, Wijmenga-Monsuur, Alienke J., Smits, Gaby, Kuijer, Marjan, van Rooijen, Debbie, Bogaard-van Maurik, Marjan, Zutt, Ilse, van Vliet, Jeffrey, Wolf, Janine, van der Klis, Fiona R. M., de Melker, Hester E., van Binnendijk, Robert S., den Hartog, Gerco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990276/
https://www.ncbi.nlm.nih.gov/pubmed/35396570
http://dx.doi.org/10.1038/s41598-022-10020-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990276/
https://www.ncbi.nlm.nih.gov/pubmed/35396570
http://dx.doi.org/10.1038/s41598-022-10020-6

Ejemplares similares